BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 335742)

  • 21. Vi-negative strains of Salmonella typhosa: attempts to induce W-V reversion and the use of non-Vi strains in evaluating typhoid vaccines.
    TULLY JG; CURRIE JA
    J Bacteriol; 1962 Oct; 84(4):747-53. PubMed ID: 13994748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibodies to Salmonella lipopolysaccharide: anti-O-polysaccharide antibodies protect C3H mice against challenge with virulent Salmonella typhimurium.
    Colwell DE; Michalek SM; Briles DE; Jirillo E; McGhee JR
    J Immunol; 1984 Aug; 133(2):950-7. PubMed ID: 6203984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Active immunization to experimental salmonellosis in mice protective properties of Salmonella R mutants against infection with different pathogenic Salmonella species (author's transl)].
    Schlecht S
    Zentralbl Bakteriol A; 1981 Aug; 249(3):362-72. PubMed ID: 7023133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of the protective immunity against murine typhoid: persistence of Salmonella L forms in the liver after immunization with live-cell vaccines.
    Kita E; Nishikawa F; Kamikaidou N; Oku D; Yasui K; Kashiba S
    FEMS Microbiol Immunol; 1992 Oct; 5(4):191-9. PubMed ID: 1419117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A chemical typhoid vaccine containing a surface-antigen complex including the K-antigen].
    Stepanova LK; Belaia IuA; Sergeeva NS; Ageeva VA; Petrukhin VG
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):51-6. PubMed ID: 7520650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against experimental salmonellosis in mice and sheep by immunisation with aromatic-dependent Salmonella typhimurium.
    Mukkur TK; McDowell GH; Stocker BA; Lascelles AK
    J Med Microbiol; 1987 Aug; 24(1):11-9. PubMed ID: 2441060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Protection against experimental Salmonella typhimurium infection in mice. Immunostimulating activity of heterologous Salmonella S-forms, R-mutants, lipopolysaccharides and muramyl dipeptide in vaccines combined with S. typhimurium].
    Schlecht S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):414-25. PubMed ID: 6385567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunity to intracellular Salmonella depends on surface-associated antigens.
    Barat S; Willer Y; Rizos K; Claudi B; Mazé A; Schemmer AK; Kirchhoff D; Schmidt A; Burton N; Bumann D
    PLoS Pathog; 2012; 8(10):e1002966. PubMed ID: 23093937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
    Paliwal PK; Bansal A; Sagi SS; Sairam M
    Vaccine; 2011 Sep; 29(38):6532-9. PubMed ID: 21767594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection.
    Mittrücker HW; Raupach B; Köhler A; Kaufmann SH
    J Immunol; 2000 Feb; 164(4):1648-52. PubMed ID: 10657605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunity conferred by Aro- Salmonella live vaccines.
    Hormaeche CE; Joysey HS; Desilva L; Izhar M; Stocker BA
    Microb Pathog; 1991 Feb; 10(2):149-58. PubMed ID: 1890952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunity induced with ribosomal fractions obtained from S. typhi T and 2 against different strains of S. typhi].
    Molinari JL; Flisser A; Cabrera R
    Rev Latinoam Microbiol; 1975; 17(3):150-6. PubMed ID: 1059218
    [No Abstract]   [Full Text] [Related]  

  • 34. Neutralization reaction of bacteriolysins and its application for the titration of salmonella O antigens.
    Tendetnik YY; Levi MI; Rukhadze EZ; Vydrina EI; Pryamukhina NS
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):104-13. PubMed ID: 4575461
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of immunity to infection with Salmonella typhimurium in outbred mice. I. Requirement of the antibody to non-O antigen for protection in mice that are not protected by the RNA-rich vaccine.
    Kita E; Nishi K; Emoto M; Katsui N; Yasui K; Yasui K; Kashiba S
    Immunology; 1987 Aug; 61(4):535-41. PubMed ID: 2450832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective role of O antigen in Salmonella typhi-murium infection.
    Jaszovszky I
    Acta Microbiol Acad Sci Hung; 1982; 29(2):105-13. PubMed ID: 6182761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunity in typhoid fever. II. Antigens and immune response in systemic salmonellosis].
    Milhomem AM; Suassuna I
    Mem Inst Oswaldo Cruz; 1982; 77(4):453-83. PubMed ID: 6764521
    [No Abstract]   [Full Text] [Related]  

  • 39. Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals.
    Wong KH; Feeley JC; Northrup RS; Forlines ME
    Infect Immun; 1974 Feb; 9(2):348-53. PubMed ID: 4205947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Salmonella porins as a broad spectrum vaccine candidate.
    Tabaraie B; Sharma BK; Sharma PR; Sehgal R; Ganguly NK
    Microbiol Immunol; 1994; 38(7):553-9. PubMed ID: 7968689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.